Reta 10mg” is a common shorthand or branding used for Retatrutide, an experimental weight-loss and metabolic medication currently in late-stage clinical trials. What is Retatrutide?Retatrutide is a “triple hormone receptor agonist” developed by Eli Lilly. Unlike current weight-loss medications (like Wegovy or Zepbound) that target one or two hormone receptors, Retatrutide is designed to target three: GLP-1 (Glucagon-like peptide-1) GIP (Glucose-dependent insulinotropic polypeptide) Glucagon By acting on all three pathways, it is being studied for its potential to suppress appetite, slow digestion, and increase energy expenditure (fat burning) more effectively than existing treatments if your looking to get some quality peptides then ordersteroidsonline.com is your one stop shop